Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Jan 11;16(1):e0240146. doi: 10.1371/journal.pone.0240146

Why the COVID-19 pandemic is a traumatic stressor

Victoria M E Bridgland 1, Ella K Moeck 1,2, Deanne M Green 1, Taylor L Swain 1, Diane M Nayda 1, Lucy A Matson 1, Nadine P Hutchison 1, Melanie K T Takarangi 1,*
Editor: Vedat Sar3
PMCID: PMC7799777  PMID: 33428630

Abstract

The COVID-19 pandemic does not fit into prevailing Post-traumatic Stress Disorder (PTSD) models, or diagnostic criteria, yet emerging research shows traumatic stress symptoms as a result of this ongoing global stressor. Current pathogenic event models focus on past, and largely direct, trauma exposure to certain kinds of life-threatening events. Yet, traumatic stress reactions to future, indirect trauma exposure, and non-Criterion A events exist, suggesting COVID-19 is also a traumatic stressor which could lead to PTSD symptomology. To examine this idea, we asked a sample of online participants (N = 1,040), in five western countries, to indicate the COVID-19 events they had been directly exposed to, events they anticipated would happen in the future, and other forms of indirect exposure such as through media coverage. We then asked participants to complete the Posttraumatic Stress Disorder Checklist-5, adapted to measure pre/peri/post-traumatic reactions in relation to COVID-19. We also measured general emotional reactions (e.g., angry, anxious, helpless), well-being, psychosocial functioning, and depression, anxiety, and stress symptoms. We found participants had PTSD-like symptoms for events that had not happened and when participants had been directly (e.g., contact with virus) or indirectly exposed to COVID-19 (e.g., via media). Moreover, 13.2% of our sample were likely PTSD-positive, despite types of COVID-19 “exposure” (e.g., lockdown) not fitting DSM-5 criteria. The emotional impact of “worst” experienced/anticipated events best predicted PTSD-like symptoms. Taken together, our findings support emerging research that COVID-19 can be understood as a traumatic stressor event capable of eliciting PTSD-like responses and exacerbating other related mental health problems (e.g., anxiety, depression, psychosocial functioning, etc.). Our findings add to existing literature supporting a pathogenic event memory model of traumatic stress.

Introduction

The COVID-19 pandemic is ravaging all areas of human life (e.g., social, financial), creating distress, and exacerbating mental health issues [1, 2]. Recent research suggests that traumatic stress reactions during the pandemic—including intrusive re-experiencing and heightened arousal—are particularly prevalent [3, 4]. But exposure to the pandemic does not fit neatly within prevailing Post-traumatic Stress Disorder (PTSD) models (pathogenic event models) [5, 6]. These models, along with the DSM-5 diagnostic criteria [7], attribute traumatic stress reactions to past, and largely direct, exposure to certain life-threatening events, and thus do not readily account for emerging evidence that COVID-19 is associated with PTSD symptomology. We propose that people’s traumatic stress reactions to the COVID-19 pandemic may relate more to: the future than the past; indirect (e.g., via media coverage) than direct (e.g., contact with the virus) exposure; and stressful events (e.g., unemployment, isolation, non-sudden illness/death) that do not meet Criterion A (i.e., actual or threatened death, injury or sexual violation). Therefore, we sought evidence for this proposal. Although we know traumatic stress reactions to future, indirect trauma exposure, and non-Criterion A events exist [8, 9], the COVID-19 pandemic gives us a unique opportunity to extend this research by considering all three factors simultaneously. Our goal was not to unnecessarily pathologize normal transient stress reactions [10], but rather to document types of “events” that lead to traumatic stress reactions and thus inform PTSD models which may—currently—not capture all people who require help for traumatic stress symptoms.

We first turn to the idea of traumatic stress as a problem of the past. Existing PTSD models largely focus on traumatic stress as a problem that occurs in response to past, not future, events. Perhaps there is a profound ontological distinction between something that has happened in the past and something that might happen in the future. Yet, Addis ([11], p. 233) argues that remembering and imagining are “fundamentally the same process” (see also [12]); both involve the mental rendering of experience. Certainly, there is convincing evidence that similar neural networks underlie remembering the past and imagining the future [13]. Thus, it is possible that problematic reactions can occur in response to any mentally rendered experience, whether it is remembered and/or imagined. Existing evidence fits with this idea: imagining future trauma—e.g., among soldiers before deployment, expectant mothers, or people anticipating the death of a loved one—can cause PTSD-related symptoms and distress at similar or higher levels than for past trauma [8, 1416]. Indeed, participants in these studies have reported—on scales adapted from traditional PTSD measures—experiencing not only more typical symptom candidates like image-based flashforwards to a specific future event, but also nonspecific symptom candidates such as heightened irritability and negative mood. Therefore, traumatic stress symptoms may be a problem of anticipating the future, as well as a reaction to something in the past [8, 15, 16]. Given the unknown timeline of COVID-19, it seems especially likely that PTSD-like symptoms could arise due to anticipating any number of negative future events (e.g., loved ones becoming sick) associated with the virus, particularly in the early weeks of the pandemic (when the current data were collected). Moreover, given COVID-19 is still unfolding, people may experience peri-traumatic reactions (responses at the time of a stressful event or immediately after).

We now examine the idea of traumatic stress arising only from direct exposure to a trauma. Early editions of the DSM provided wide and ambiguous definitions of trauma exposure. For example, when PTSD was first introduced in the DSM-III, traumatic events were characterized as catastrophic stressors outside the range of normal human experience [17]. This definition was tightened in the DSM-IV, which stated that people could either witness or be “confronted with” events that involved threatened death or serious injury [18]. In an effort to further refine the definition, DSM-5 [7] specifies that a person must directly experience (Criterion A1) or witness a traumatic event (A2). Two exceptions to this rule encompass indirect exposure: learning that a loved one has suddenly died in a violent/accidental way (A3), or exposure to others’ traumatic experiences (A4: termed “vicarious trauma” e.g., first responders collecting human remains). However, Criterion A4 specifically excludes exposure via electronic media—unless this exposure is work related (e.g., police officers repeatedly exposed to child exploitation images). Yet, PTSD symptomology is also found among members of the general public who are exposed only to traumatic material, usually via news media. For example, media exposure was associated with higher acute stress than direct exposure to the Boston Marathon bombings [19]. In China, nurses not involved in caring for COVID-19 patients (non-front-line nurses) and the general public had higher PTSD-like symptoms (e.g., intrusive thoughts), depression, anxiety, and stress symptoms, and physiological reactions (e.g., no appetite), than front-line nurses [20]. Li et al. [20] speculated that perhaps non-front-line nurses and the general public consumed more COVID-19 media. Recent evidence supports this interpretation: exposure to COVID-19 related news in the initial stages of the outbreak was associated with negative affect, anxiety, depression and stress [21]. Moreover, searching for additional information about COVID-19 via traditional and social media was related to increased fear about consequences of the virus [22]. Therefore, it seems possible that indirect exposure to the pandemic, such as via the 24-hour news cycle, could produce PTSD-like symptoms.

Last, we turn to the idea of traumatic stress arising only from exposure to actual or threatened death, serious injury or sexual violation (i.e., only to certain kinds of serious events). Under the current DSM-5 diagnostic criteria, traumatic stress symptoms following events that do not involve an immediate threat to life or physical injury—such as divorce, job loss, or non-sudden medical events—do not qualify for a PTSD diagnosis. Yet, we know PTSD symptoms arise after a range of events that do not meet this narrow definition [9]. For example, ongoing financial stressors and low social support following Hurricane Katrina, not only direct exposure to hurricane-related events, were associated with PTSD symptoms measured 18–24 months post-hurricane [23]. Notably, financial stressors independently predicted PTSD symptom duration, while hurricane-related traumatic events did not. Similarly, receiving a cancer diagnosis does not meet DSM-5 criteria specifying a “sudden and catastrophic” medical event [24]. Yet, 6–20% of cancer sufferers and their families are diagnosed with cancer-related PTSD [24]—although the true prevalence of cancer-related PTSD is likely much higher. Indeed, one of the main reasons that people who met DSM-IV diagnostic criteria do not meet DSM-5 criteria is the elimination of non-sudden death of a loved one as a Criterion A1 event [25]. Thus, direct exposure to a past event that threatens death, injury, or sexual violation is not the only precipitator of PTSD-like symptoms. Again, these data suggest that a range of COVID-19 related stressful events (e.g., job loss, isolation) could lead to traumatic stress symptoms, despite even the direst of COVID-19 events not meeting stringent DSM-5 criteria that state medical events must be sudden and “catastrophic” [7].

In summary, our primary prediction was that people would report experiencing pre-, post-, and peri-traumatic stress reactions in response to COVID-19, regardless of whether they had been directly (e.g., COVID-19 diagnosis) or indirectly (e.g., through media) exposed to the virus, or had other negative experiences (e.g., lockdown). As a secondary aim, we were interested in capturing a snapshot of people’s psychological (rather than immunological) response to the virus. We expected that pre/peri/post-traumatic stress reactions, as well as other psychological functioning indicators (well-being, psychosocial impairment, emotions, depression, anxiety, and stress) would fluctuate alongside COVID-19 exposure, and that psychological functioning would vary by demographics (e.g., age, healthcare).

We recruited online participants from five English speaking western countries of similar socio-economic make up (United States, United Kingdom, Canada, Australia and New Zealand). To date, research on COVID-19 as a traumatic stressor has primarily been conducted in China [3], and only one unpublished study has focused on one of our populations of interest (United States [26]). Furthermore, published research to date has focused on providing a snapshot of mental health related concerns (e.g., rates of PTSD, depression etc.), rather than exploring why COVID-19 may be considered a traumatic stressor [1, 2]. Here, to investigate why COVID-19 may be a traumatic stressor, we asked participants to indicate the COVID-19 events they had experienced and what future events they were concerned about (see Supplementary Online Material: https://osf.io/jn7zx/), and of these, which event bothered/bothers them the most and why. We also measured COVID-19 media consumption. Participants completed the Posttraumatic Stress Disorder Checklist-5 (PCL-5 [27]), adapted to measure pre/peri/post-traumatic reactions, and measures of general emotional reactions, well-being, psychosocial functioning, and depression, anxiety, and stress symptoms. Although emerging research on COVID-19 and traumatic stress reactions has typically not specified whether participants anchored their reactions to COVID-19 itself (e.g., [28]), we asked our participants to respond to the PCL-5 in relation to COVID-19. In doing so, we reduced the likelihood that participants were reporting general (i.e., unrelated to the pandemic) levels of stress or anxiety.

Method

This experiment was approved by the Flinders University Social and Behavioural Research Ethics Committee. We have reported all measures, conditions, and data exclusions. We preregistered this experiment (https://osf.io/dxhek), and together with the data file, all supplementary material—including full demographic breakdown, analyses by country, and other descriptive and inferential statistics—can be found under this project:https://osf.io/jn7zx/ https://osf.io/jn7zx/.

Participants

Correlations stabilize when sample size approaches 260 [29]. We excluded 18 responses: five provided answers consistent with bots/farmers (e.g., “interested”), and 13 took the survey twice. Thus, after exclusions, we collected 260 participants in each of four locations (Australia/NZ combined for analysis; a participant error resulted in 261 participants from Canada, and 259 from Australia/NZ), from Mechanical Turk (MTurk; n = 320) and Prolific (n = 720) between April 10–21, 2020, exceeding the pre-registered sample size (N = 1,000). We know that MTurk data are reliable [30, 31] and sometimes even superior to university sourced participants (e.g., participants fail fewer attention checks [32]). Prolific data appear to be as reliable as MTurk, and similar, if not superior to, university research pools [33]. Further, the prevalence of mental health disorders in MTurk populations matches or exceeds that of the general population [34], suggesting MTurk is an excellent source for collecting clinical and subclinical populations. We specifically abide by Mellis and Bickel’s [35] advice for conducting online research, to mitigate concerns in these populations (e.g., non-naivete, worker inattention, fraudulent responses and worker treatment). To minimize “bots”/server farmers completing the survey [36, 37], participants had to pass a captcha, a simple arithmetic question (presented as an image to make it difficult for bots to read), and score at least 8/10 on an English proficiency test. We are confident that these entry requirements screened out almost all bots/server farmers; in one estimate, the addition of an English proficiency test screened out 96% of bots/server farmers [38]. In addition to these entry requirements, participants had to pass at least one of three attention check questions embedded in the survey itself to be included in the final sample [39, 40].

Participants ranged from 18–78 years (M = 35.7, SD = 12.3), half were male (50.70%, female = 48.8%, non-binary = 0.4%; 0.2% did not answer) and most were Caucasian 59.9%. Others were of Asian (13.4%); African (including “Black”, 4.7%); Middle Eastern (including “Eurasian”, 0.8%); European (3.5%); and Hispanic (1.2%) descent, or Indigenous (0.3%); Pacific Islander (0.1%); Mixed (3.3%) ethnicity. Some participants provided nationality (e.g., “Australian” 12.8%) or no answer (0.2%). Seventy percent were employed, 19.8% were students. Participants’ highest level of education was a college/university undergraduate degree (54.8%), postgraduate degree (18.7%), high school (25.6%); 1.0% < high school. Participants had a median of three people in their household (including themselves). Modal household income was (local currency): Australia/NZ = $100,000-$149,999, Canada = $100,000-$149,000, UK = £20,000-£29,999, US = $50,000-$59,999. Most participants (88.8%) had health-care coverage for COVID-19 expenses and were not in a high-risk group (82.6%) for developing COVID-19 (e.g., elderly, medical condition; 14.9% of participants identified as high risk, 2.5% did not know). Just under half (45.2%) had experienced a Criterion A event.

Materials

We first asked demographic questions, described above. Note that other pre-registered measures (i.e., media avoidance, engagement with fictional/non-fictional media, perceptions of sharing the pandemic with others) are not reported here.

General emotional reactions

We assessed current stress (0 = no stress, 10 = worst stress possible), and, when thinking about COVID-19, how intensely participants felt negative emotions (sad, angry, anxious, frustrated, helpless, fearful, disgusted; 0 = not at all, 7 = extremely). We averaged these emotion items (α = .89).

Exposure to COVID-19 and related impact

We provided a list of 32 COVID-19 related events (ranging from exposure to the virus itself to stressors like job loss; see Supplementary Online Material:https://osf.io/tkemz/ https://osf.io/tkemz/), within nine predetermined categories. Participants selected all the events they had experienced, with an option for ‘other’ leading us to create four additional––and modify 10––categories. We recategorized seven “other” responses into new categories and 37 into modified/existing categories. We then re-presented the same list of events, but asked participants to select events they were concerned about happening in the future (“other” events led to three additional categories [seven responses recategorized] and eight modified categories [15 recategorized]). For both lists, participants identified which of their selected events bothered them the most and why (text response), and how much it bothered them emotionally (1 = not at all, 5 = very much).

Media exposure

Participants identified the social media (e.g., Facebook) and news media (e.g., television) sources used to engage with COVID-19 content. We assessed frequency of use (how many: hours in the past day, days in the past week, average hours in the past week), and combined these items to create separate scores for both media types.

The PTSD Checklist (PCL-5 [27])

Participants rated how much they have been bothered by 20 DSM-5 PTSD symptoms (e.g., “having difficulty concentrating”; 0 = not at all, 4 = extremely; current study α = .92). We made three modifications: measured symptoms in relation to COVID-19 experiences, over the past week (rather than month) due to the rapidly changing circumstances, and asked participants to indicate if each symptom (rated > 0) related to something that happened in the past, was currently happening, or may happen in the future.

The 5-item World Health Organization Well-Being Index (WHO-5 [41])

Participants rated how five statements (e.g., “I have felt calm and relaxed”) applied to them over the past week (0 = at no time, 5 = all of the time). Total scores (0–25) are multiplied by four to provide a percentage score (0 = worst possible quality of life, 100 = best possible quality of life; current study: α = .90).

Brief Inventory of Psychosocial Functioning (B-IPF [42])

Participants rated how much (0 = not at all, 6 = very much) trouble they have had with seven impairment domains (e.g., work) over the past week (e.g., “I had trouble at work”; current study: α = .85).

Depression, Anxiety and Stress Scale (DASS-21 [43])

Participants rated the degree to which each statement (e.g., “I felt down-hearted and blue”) applied to them over the past week (0 = did not apply to me at all, 3 = applied to me very much). Current study: Depression, α = .92; Anxiety, α = .86; Stress, α = .90.

Results

For context, over our 12 days of data collection, confirmed cases worldwide increased from ~1.7 to ~2.5 million (deaths from ~102,000 to ~170,000). In the US, total cases jumped from 500,000 to over 750,000, President Trump released the “Opening Up America Again” plan, while protests to remove restrictions increased. In the UK, Prime Minister Johnson was released after hospitalization for COVID-19, the Queen addressed the nation, and lockdown restrictions were extended. In Canada, deaths reached 1,500, and an unrelated shooting occurred in Nova Scotia. In Australia/NZ, lockdown procedures were introduced or maintained, and both countries showed signs of reduced COVID-19 spread from the first wave.

We ran analyses using Null-Hypothesis Significance Tests (α = .05) in SPSS Version 25 and JASP for MacOS version 0.13.1 [44]. Where data were missing, we used the average mean score from the appropriate subscale. In total there were only six missing data points from five participants: two participants missed items on the Posttraumatic Stress Disorder Checklist (PCL-5; one participant missed two items), two participants missed one item on the WHO-5 (measure of wellbeing), and one participant missed one item on the Depression, Anxiety and Stress Scale (DASS-21).

First we present a snapshot of COVID-19’s effect on mental health. Descriptive statistics for overall stress, emotional reactions and psychological functioning ratings appear in Table 1.

Table 1. Descriptive statistics–emotion and psychological functioning variables (full sample).

Range Mean Median SD
Pre/Peri/Post-Traumatic Stress Reactions (PCL-5) 0–66 17.37 14.00 13.29
    Re-experiencing 0–20 3.51 2.00 3.82
    Avoidance 0–8 2.01 1.00 2.04
    Alterations in cog/mood 0–26 6.78 6.00 5.36
    Alterations in arousal 0–24 5.07 4.00 4.21
Stress 0–10 4.99 5.00 2.39
Negative emotions 1–7 3.72 3.86 1.40
Physical Disgust 1–7 3.74 4.00 1.84
Moral Disgust 1–7 5.33 6.00 1.57
Wellbeing (WHO-5) 0–100 46.27 48.00 22.53
Psychosocial Functioning (B-IPF) 0–100 24.42 20.00 22.43
Depression (DASS-21) 0–42 12.50 10.00 11.22
Anxiety (DASS-21) 0–42 6.43 4.00 8.07
Stress (DASS-21) 0–42 12.50 10.00 10.38

These variables were highly correlated. According to the conservative cut-off for clinical significance for PCL-5 scores (< 32 = negative, ≥ 33 = positive) [45], 13.2% of our participants could be classified PTSD-positive. For depression, 47.3% of our participants were in the normal range; 28.8% mild-moderate; 24.0% severe-extremely severe (Depression, Anxiety and Stress Scale [DASS-21] manual cut-offs). For anxiety: 68.0% normal, 15.9% mild-moderate, 16.1% severe-extremely severe; and for stress: 63.0% normal, 22.6% mild-moderate, 14.4% severe-extremely severe. Participants’ mean DASS-21 scores were higher than non-clinical samples [46]. For well-being, 55.4% of participants scored below 50 (0 = worst, 100 = best). Overall well-being was below the UK population mean of 58.6 [47]. For psychosocial functioning, 64.0% of participants reported some impairment due to COVID-19. Completing day-to-day activities (e.g., chores, medical appointments; self-care subscale: 62.8%) was most common. Troubles with training/education (27.6%) created the highest level of impairment (M = 3.3, SD = 1.7).

Taken together, our findings support emerging research [1, 2, 4] that COVID-19 is associated with PTSD-like symptomology and other mental health issues. Next we addressed our main aim—to examine evidence for our proposal that people are experiencing traumatic stress symptoms as a result of COVID-19 because direct exposure to a past event that threatens death, injury, or sexual violation, is not the only circumstance capable of precipitating PTSD-like symptoms.

First, we examined evidence that traumatic stress is a problem not only of remembering the past, but also of anticipating the future. We calculated the frequency of exposure to experienced and anticipated COVID-19 events. On average, participants anticipated (M = 8.98, SD = 5.24) more events than they had experienced (M = 6.34, SD = 2.74; d = 0.49). The most common worst experiences were being in lockdown (13.1%), trouble obtaining supplies (11.2%), and voluntarily self-isolating (10.8%). The most common worst anticipated experience was close family/friends passing away (38.1%), followed by becoming ill or passing away (22.2%), and close family/friends testing positive (9.2%). However, worst anticipated and experienced event judgements were fairly evenly distributed across our full list.

We next examined whether traumatic stress reactions were associated with anticipated (and experienced) events. We found small correlations between PTSD-like symptoms and total experienced (r = .20, p < .001) and anticipated (r = .23 p < .001) events. Both exposure measures weakly correlated with other stress and psychological functioning measures (experienced: rs = .10-.19; anticipated: rs = .12-.22).

However, because examining event totals tells us nothing about how distressing each experienced/anticipated event was, we next focused on our nine event categories, and participants' worst experienced and anticipated events. Participants who had contact with the virus (d = 0.34, 95% CI [0.20, 0.47]), lost work/income (d = 0.18 [0.05, 0.30]), experienced lockdown directives (d = 0.13 [0.004, 0.25]), changes to children/dependents (d = 0.15 [0.02, 0.28]), and had trouble buying supplies (d = 0.34 [0.22, 0.46]) reported higher PTSD symptoms than participants not reporting these experiences. However, there was no difference based on whether people experienced changes to work/education, travel plans, closure of non-essential gatherings, or voluntarily self-isolated (ds 0.02–0.11). Similarly, participants who anticipated contact with the virus (d = 0.44, 95% CI [0.15, 0.72]), losing work/income (d = 0.25 [0.12, 0.37]), lockdown directives (d = 0.15 [0.03, 0.28]) and changes to children/dependents (d = 0.35 [0.18, 0.51]) had higher PTSD symptoms than participants who did not anticipate these events. Contrary to experienced events, participants who anticipated changes to work/education (d = 0.38, [0.16, 0.61]), travel plans (d = 0.26 [0.12, 0.40]), and closure of non-essential gatherings (d = 0.29 [0.07, 0.50]) reported higher PTSD symptoms than participants who did not anticipate these events. There was no difference based on whether people anticipated voluntarily self-isolating (d = 0.24 [0.01, 0.46]), or having trouble buying supplies (d = 0.12 [-0.02, 0.25]).

On average, participants’ worst anticipated event (M = 3.97, SD = 1.04) was more emotionally bothersome than their worst experienced event (M = 3.35, SD = 1.15; two-tailed paired samples: t (1039) = -18.18, p < .001, d = 0.56, 95% CI [0.50, 0.63]). Both ratings strongly correlated with PTSD symptoms (experienced: r = .48; anticipated: r = .45) and other stress and psychological functioning measures (experienced: rs .30-.51; anticipated: rs .25 - .46). However, total PCL score does not tell us how often participants attributed symptoms to experienced and anticipated events, or something currently happening. Nearly half (48.1%) of participants reported symptoms in relation to all time periods (23.3% past/future, 7.5% past/current, 0.8% past/future; 14.5% current, 0.2% past, 1.7% future; 3.9% reported no symptoms). Some participants failed to index individual symptoms to a timeframe; 0.6% did not index any. Notably, 73.5% of participants reported at least one symptom related to something that had not happened. These symptoms fell into all four symptom clusters (50.1% of participants attributed intrusion symptoms to the future; 15.4% avoidance, 48.0% hyperarousal and 56.5% cognition and mood). In other words, PTSD-like symptoms for events that had not yet happened did not only manifest as intrusive thoughts (which might be narrowly conceptualized as worries about the future) but also as nonspecific symptoms such as irritability and alertness.

Second, we examined whether traumatic stress reactions occurred regardless of direct versus indirect exposure to COVID-19. Participants reporting PTSD symptoms in relation to future events already supports this prediction. In addition, we found small correlations between COVID-19 related social media consumption (r = .18, p < .001) and PTSD symptoms, and all psychological functioning variables (rs = .09 - .20) except well-being; and between traditional media consumption and PTSD symptoms (r = .12, p < .001), stress, and negative emotions (rs = .14, p < .001), but not other psychological functioning variables. Although small, considering the average adult spends three hours and 30 minutes a day on a mobile device—equating to 53 days in a year and countless exposure to news media [48]—these effects could rapidly accumulate, leading to adverse consequences [49].

Third, we examined evidence that PTSD-like symptoms occur for events that do not involve actual or threatened death, injury, or sexual violation. Arguably, none of our events/categories meet Criterion A; medically-based trauma is limited to sudden catastrophe (e.g., waking during surgery, anaphylactic shock [7]). Even our most extreme direct exposure variables (e.g., being hospitalized in a critical condition) do not qualify. Therefore, it is troubling that 13.2% of participants could be classified as PTSD-positive when anchoring the PCL-5 to COVID-19. We explored whether PTSD-positive participants had direct exposure to the virus via events which, while not classed as Criterion A, could be life threatening. Direct exposure included personally testing positive or being hospitalized as a result of COVID-19, or suspecting you may have been exposed to the virus, or knowing close others (e.g., family/friends) who have tested positive, were hospitalized, or who have passed away, as a result of COVID-19. Overall, of the 13.2% of participants who were classed as PTSD-positive, 60.6% were participants who were not directly exposed to the virus (versus those directly exposed; 39.4%; χ2 (1) = .031, φ = .067). However, it should be noted that roughly double the number of participants had been indirectly, rather than directly exposed to the virus. Indeed, when examining within these groups, more participants who had some form of direct virus exposure (n = 327) were PTSD-positive (16.5%), than participants who had no virus exposure (n = 713; PTSD-positive = 11.6%). These data suggest that having direct contact with the virus (e.g., one’s self or a family member being diagnosed) did result in increased PTSD-like symptomology versus people who were only indirectly exposed (e.g., affected by lockdown). Additionally, there was no difference in the percentage of PTSD-positive participants who had experienced (6.8%) or not (6.3%) a Criterion A event previously, suggesting participants anchored PCL-5 responses to COVID-19 experiences rather than other lifetime traumas.

Together, these data support our proposal that PTSD-like reactions can occur in relation to past, ongoing, and future events, indirect event exposure, and for a variety of stressors not covered by Criterion A. To examine the relative contribution of our exposure variables, while also controlling for demographic variables that could increase participants’ susceptibility to PTSD symptoms, we regressed PCL-5 total on these variables. For all regression analyses, tolerance and variance inflation factors showed multicollinearity was not an issue.

First, we examined which demographic variables related to PTSD-like reactions. PTSD symptomology (PCL-5 total scores) was higher for participants from the United Kingdom (vs. Australia/New Zealand: d = 0.35, 95% CI [-0.52, -0.17], and vs. the United States: d = 0.45, [0.27, 0.62]), and Canada (vs. United States: d = 0.33, [0.16, 0.51]). Further, scores were higher for females (d = 0.41, [0.29, 0.54]), students (d = 0.16, [0.01, 0.32]), people at high risk of contracting COVID-19 (d = 0.30, [0.14, 0.46]), and people with lifetime Criterion A trauma (d = 0.31, [0.18, 0.43]), and were weakly correlated with age and income (rs < .10). For categorical variables, dummy variables were created as per the protocol Field [50] describes. For country of residence, we selected the United States as the baseline group (i.e., the group which is always assigned 0 in each dummy variable) because participants from the United States reported the lowest level of PTSD symptoms. After entering these variables into a single step of a simultaneous regression, we found that country of residence, age, sex, risk status, and prior Criterion A exposure best predicted PTSD symptomology (10.2% of the variance; F(9, 1031) = 13.95, p < .001).

To examine the unique additional variance explained by actual and anticipated exposure to COVID-19 (event totals), media consumption (social and traditional media summed), and the emotion associated with worst events (experienced and anticipated), we then ran a hierarchical regression with demographic predictors (identified in our simultaneous regression) entered at Step 1, exposure variables at Step 2, and emotion variables at Step 3. After controlling for demographics, exposure variables explained an additional 7.1% of the variance in PTSD symptomology (Fchange (3, 1020) = 29.23, p < .001). Importantly, emotion associated with worst events explained an additional 16.2% of the variance in PTSD symptomology (Fchange (2, 1018) = 125.26, p < .001; regression coefficients and standard errors appear in Table 2). The final model explained 33.3% of the variance in PTSD symptomology (F (12, 1030) = 43.86, p < .001), and, notably, experienced event totals was no longer a significant predictor. In sum, the emotion associated with participants’ worst experienced and worst anticipated events was the strongest predictor of PTSD symptomology, above and beyond demographic variables and measures of direct and indirect exposure to COVID-19 related events.

Table 2. Regression analysis summary for demographic factors, exposure variables, and the emotion associated with worst events (experienced and anticipated) predicting PCL total scores.

Model B 95% CI Β
Step 1 Constant 25.49 [20.97, 30.01]
Age -0.16 [-0.23, -0.08] -.15**
Household income -0.07 [-0.32, -0.18] -.02
Sex 4.01 [2.42, 5.60] .15**
Risk status -4.71 [-6.87, -2.55] -.13**
Lifetime trauma exposure -3.30 [-4.88, -1.71] -.12**
Student status -0.33 [-2.53, 1.87] -.01
Australia/NZ vs. US -0.18 [-2.52, 2.15] -.01
Canada vs. US 2.60 [0.31, 4.88] .08*
UK vs. US 5.34 [3.08, 7.59] .17**
Step 1 Constant 25.20 [20.95, 29.5]
Age -0.16 [-0.23, -0.09] -.15**
Sex 3.98 [2.40, 5.56] .15**
Risk status -4.75 [-6.89, -2.61] -.14**
Lifetime trauma exposure -3.37 [-4.96, -1.79] -.13**
Australia/NZ vs. US -0.21 [-2.48, 2.07] -.01
Canada vs. US 2.49 [0.24, 4.74] .08*
UK vs. US 5.37 [3.17, 7.58] .18**
Step 2 Constant 10.79 [5.51, 16.07]
Age -0.16 [-0.23, -0.09] -.15**
Sex 3.62 [2.09, 5.16] .14**
Risk status -4.22 [-6.29, -2.16] -.12**
Lifetime trauma exposure -2.62 [-4.17, -1.07] -.10*
Australia/NZ vs. US -0.25 [-2.45, 1.95] -.01
Canada vs. US 2.05 [-0.12, 4.22] .07
UK vs. US 4.63 [2.49, 6.76] .15**
Media consumption total 0.32 [0.20, 0.43] .16**
Total experienced events 0.38 [0.09, 0.67] .08*
Total anticipated events 0.45 [0.30, 0.59] .18**
Step 3 Constant -6.71 [-12.01, -1.41]
Age -0.10 [-0.16, -0.43] -.10*
Sex 1.36 [-0.05, 2.76] .05
Risk status -2.80 [-4.66, -0.94] -.08*
Lifetime trauma exposure -2.60 [-3.99, -1.21] -.10**
Australia/NZ vs. US 0.37 [-1.60, 2.35] .01
Canada vs. US 1.88 [-0.07, 3.84] .06
UK vs. US 4.26 [2.35, 6.18] .14**
Media consumption total 0.16 [0.06, 0.27] .08*
Total experienced events -0.01 [-0.27, 0.26] <-.01
Total anticipated events 0.26 [0.12, 0.39] .10**
Experienced worst event emotion 3.30 [2.61, 3.99] .28**
Anticipated worst event emotion 3.04 [2.28, 3.81] .23**

Note

* p < .005

** p < .001

Discussion

Overall, we found that participants had PTSD-like symptoms for events that had not yet happened, challenging the nature of traumatic stress as a problem pertaining only to the past. Participants reported these reactions whether they had been directly (e.g., COVID-19 diagnosis) or indirectly exposed (e.g., via media) to COVID-19, challenging the idea that people need to experience a direct, in person event to develop PTSD-like symptoms. Finally, 13.2% of our sample were PTSD-positive, despite COVID-19 “exposure” not fitting within Criterion A. The emotion associated with participants’ worst experienced and anticipated events predicted PTSD-like symptoms beyond demographic and exposure variables, suggesting that subjective evaluations of emotional impact may be more important in determining traumatic stress reactions than individual characteristics or objective levels of exposure.

Dominant pathogenic event models focus on PTSD arising for specific kinds of external events, and emphasize factors during/after encoding, including differential processing for perceptual (e.g., sensory) versus conceptual (e.g., meaning) details, and poor integration of the trauma in autobiographical memory [5, 6]. Thus, they do not account for symptoms in response to anticipated events, indirect exposure to trauma, or events that do not meet Criterion A. Our findings fit instead with a pathogenic event memory model, which accounts for traumatic stress in response to future and/or imagined events [51].

Of course, an alternative explanation of our data for anticipated events is that they simply reflect people expressing distress—including negative or threatening thoughts and images—about potential threats looming in their future, which may reflect worry, or a generalized anxiety disorder [7, 52]. Indeed, the PCL-Civilian scale—which is indexed to “stressful life experiences” rather than a specific trauma—correlates highly with measures of depression and general anxiety, suggesting that without the anchor to a specific trauma, the PCL-5 may pick up negative emotionality more generally [53]. However, we did ask people to indicate specific events that had happened to them, or that they were concerned about happening in the future, and then index their symptoms in relation to COVID-19. Therefore, it seems likely participants were thinking about specific COVID-19 related events rather than unknown/non-specific future events. Asking participants to index their symptoms to COVID-19 related events is key, since symptoms of PTSD are focused on specific events, whereas Generalized Anxiety Disorder involves feelings of anxiety across a wide range of circumstances and situations (e.g., about health or financial concerns). Indeed, hallmark symptoms of PTSD such as intrusions or avoidance have intentionality or “aboutness” [54]. That is, the intrusive thoughts are about something, and the person is avoiding reminders of something—that something being the traumatic event [54].

Our findings may also reflect the “hedonic treadmill” [55], whereby mildly stressful events feel more negative against the backdrop of relatively stress-free lives, particularly in the context of data from western countries, as we measured here. This explanation does not diminish that our participants were experiencing genuine distress, but explains why exposure to events like government lockdowns and inability to source supplies was associated with traumatic stress symptoms—and in some cases, above clinical cut-off levels.

Although our data suggest that COVID-19 could be understood as a traumatic stressor, this conceptualization might contribute to the problem of “conceptual bracket creep” [10]. Thus, we must consider the difference between genuine symptoms of a disorder and normal stress reactions. Failure to do so may undermine efforts to understand the psychological mechanisms that contribute to PTSD symptoms. Indeed, while here we aimed to advance understanding of why COVID-19 may be a traumatic stressor and how it may be understood using existing PTSD frameworks, other researchers have taken a step further, advocating for COVID-19 unique disorders such as “COVID stress syndrome” [56] and “COVID-19 phobia” [57]. Given the novel nature of the COVID-19 pandemic, and its continuing global impact, there is little doubt that the way we characterize the psychological impact of COVID-19 will change as our understanding grows.

COVID-19’s psychological fallout has been dubbed the “second curve,” predicted to last for months to years. Notably, while most of our participants reported experiencing some form of psychological distress and 13.2% of our sample were likely PTSD positive when anchoring symptoms to COVID-19, only 2% of our total sample reported they had personally tested positive to COVID-19, and only 5% reported that close family and friends had tested positive. It therefore seems likely that the psychological fallout from COVID-19 may reach further than the medical fallout. Short term, our findings highlight the need to focus on the acute psychological distress—especially the perceived emotional impact of particular events—associated with COVID-19 and support other emerging research that demonstrates the damaging psychological impact of COVID-19 on mental health [14]. Our results also support the WHO recommendation [58] to minimize consumption of COVID-19 media. Long-term, comprehensive documentation of COVID-19 related traumatic stress reactions will allow health professionals to help people who could otherwise fall through the cracks.

Our research has limitations. First, we used the PCL-5, a self-report measure, to examine PTSD-like symptoms cross-sectionally. The Clinician Administered PTSD Scale [59] is a more comprehensive measure that identifies the frequency and intensity of PTSD-like symptoms for an indexed event and allows a clinician to diagnose if PTSD might be present. However, we wanted to capture PTSD-like symptoms in a large sample across multiple locations that were at different points of the pandemic at the time, a goal that could not be achieved using a clinician administered scale. Second, the Clinician Administered PTSD Scale can only be completed on clients who have experienced a Criterion A event. Here, our aim was to examine traumatic stress reactions to any type of COVID-19 event that might produce such symptoms, rather than events specifically falling within this category. Similarly, we cannot determine whether symptom levels in our sample would qualify for a PTSD diagnosis. Future research could use experience-sampling methods to capture longitudinal symptoms, or a clinician administered scale to diagnose PTSD.

Second, our sample only examined five Western, English speaking countries similar in culture and socio-economic status. As such, we can only cautiously generalize these findings to other parts of the world. Third, although our data provide evidence for the potential psychological fallout of the COVID-19 pandemic, we did not investigate any personality traits, or external factors such as social support or other coping strategies, that might moderate this response. Finally, we only asked participants to focus on negative outcomes of COVID-19; future research could examine positive outcomes (e.g., growth, resilience).

COVID-19 related traumatic stress symptoms expose weaknesses in dominant PTSD models, which fail to account for traumatic stress reactions arising from anticipated, indirect, or non-life threatening stressors. This study clearly demonstrates that a single global event can lead to PTSD symptoms for a range of anticipated, indirect, and non-life threatening stressors. As Horesh and Brown [60] state, there is a clear need to expand PTSD models and in turn, better capture all people who need help for traumatic stress symptoms.

Data Availability

The authors preregistered this experiment (https://osf.io/dxhek), and together with the data file, all supplementary material—including full demographic breakdown, analyses by country, and other descriptive and inferential statistics—can be found under this project: https://osf.io/jn7zx/.

Funding Statement

MKTT and EKM received funding for this research from the College of Education, Psychology and Social Work at Flinders University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China. IJERPH. 2020. March 6;17(5):11–7. 10.3390/ijerph17051729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ren Z, Zhou Y, Liu Y. The psychological burden experienced by Chinese citizens during the COVID-19 outbreak: prevalence and determinants. BMC Public Health. 2020. December;20(1):1617 10.1186/s12889-020-09723-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cooke JE, Eirich R, Racine N, Madigan S. Prevalence of posttraumatic and general psychological stress during COVID-19: A rapid review and meta-analysis. Psychiatry Res. 2020. October;292:113347 10.1016/j.psychres.2020.113347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhang Q, Zheng R, Fu Y, Mu Q, Li J. Post traumatic stress disorder and death anxiety symptoms during the Coronavirus epidemic in 2019: A cross-sectional study based on the affected population [Internet]. ResearchSquare; 2020. October [cited 2020 Nov 24] p. 1–16. Available from: https://www.researchsquare.com/article/rs-80116/v1 [Google Scholar]
  • 5.Brewin C, Dalgleish T, Joseph S. A dual representation theory of posttraumatic stress disorder. Psychol Rev. 1996;103(4):670–86. 10.1037/0033-295x.103.4.670 [DOI] [PubMed] [Google Scholar]
  • 6.Ehlers A, Clark DM. A cognitive model of posttraumatic stress disorder. Behav Res Ther. 2000. April;38(4):319–45. 10.1016/s0005-7967(99)00123-0 [DOI] [PubMed] [Google Scholar]
  • 7.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Washington, DC; 2013.
  • 8.Berntsen D, Rubin DC. Pretraumatic stress reactions in soldiers deployed to Afghanistan. Clin Psychol Sci. 2015. September;3(5):663–74. 10.1177/2167702614551766 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gold SD, Marx BP, Soler-Baillo JM, Sloan DM. Is life stress more traumatic than traumatic stress? J Anxiety Disord. 2005. January;19(6):687–98. 10.1016/j.janxdis.2004.06.002 [DOI] [PubMed] [Google Scholar]
  • 10.McNally RJ. Remembering trauma Harvard University Press; 2003. [Google Scholar]
  • 11.Addis DR. Mental Time Travel? A Neurocognitive Model of Event Simulation. Rev Phil Psych. 2020. June;11(2):233–59. [Google Scholar]
  • 12.Rubin DC, Umanath S. Event memory: A theory of memory for laboratory, autobiographical, and fictional events. Psychological Review. 2015. January;122(1):1–23. 10.1037/a0037907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Schacter DL, Addis DR, Hassabis D, Martin VC, Spreng RN, Szpunar KK. The future of memory: Remembering, imagining, and the brain. Neuron. 2012. November;76(4):677–94. 10.1016/j.neuron.2012.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Goutaudier N, Bertoli C, Séjourné N, Chabrol H. Childbirth as a forthcoming traumatic event: pretraumatic stress disorder during pregnancy and its psychological correlates. J Reprod Infant Psychol. 2019. January;37(1):44–55. 10.1080/02646838.2018.1504284 [DOI] [PubMed] [Google Scholar]
  • 15.Gilliland G, Fleming S. A comparison of spousal anticipatory grief and conventional grief. Death Stud. 1998. August;22(6):541–69. 10.1080/074811898201399 [DOI] [PubMed] [Google Scholar]
  • 16.Rubin DC. Schema-driven construction of future autobiographical traumatic events: The future is much more troubling than the past. J Exp Psychol Gen. 2014;143(2):612–30. 10.1037/a0032638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd ed. Washington, DC; 1980.
  • 18.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC; 1994.
  • 19.Holman EA, Garfin DR, Silver RC. Media’s role in broadcasting acute stress following the Boston Marathon bombings. Proc Natl Acad Sci. 2014. January 7;111(1):93–8. 10.1073/pnas.1316265110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Li Z, Ge J, Yang M, Feng J, Qiao M, Jiang R, et al. Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control. Brain Behav Immun. 2020. March;916–9. 10.1016/j.bbi.2020.03.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chao M, Xue D, Liu T, Yang H, Hall BJ. Media use and acute psychological outcomes during COVID-19 outbreak in China. J Anxiety Disord. 2020. May;74:102248 10.1016/j.janxdis.2020.102248 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mertens G, Gerritsen L, Duijndam S, Salemink E, Engelhard I. Fear of the coronavirus (COVID-19): Predictors in an online study conducted in March 2020. J Anxiety Disord. 2020. June 10;102258 10.1016/j.janxdis.2020.102258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Galea S, Tracy M, Norris F, Coffey SF. Financial and social circumstances and the incidence and course of PTSD in Mississippi during the first two years after Hurricane Katrina. J Traum Stress. 2008. August;21(4):357–68. 10.1002/jts.20355 [DOI] [PubMed] [Google Scholar]
  • 24.Cordova MJ, Riba MB, Spiegel D. Post-traumatic stress disorder and cancer. Lancet Psychiatry. 2017. April;4(4):330–8. 10.1016/S2215-0366(17)30014-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Friedman MJ. Finalizing PTSD in DSM-5: Getting Here From There and Where to Go Next. Journal of Traumatic Stress. 2013;26(5):548–56. 10.1002/jts.21840 [DOI] [PubMed] [Google Scholar]
  • 26.Park A, Velez CV, Kannan K, Chorpita BF. Stress, functioning, and coping during the COVID-19 pandemic: Results from an online convenience sample [Internet]. PsyArXiv; 2020. Jun [cited 2020 Sep 16]. Available from: https://osf.io/jmctv [Google Scholar]
  • 27.Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD Checklist for DSM-5 (PCL-5). 2013; Available from: www.ptsd.va.gov [Google Scholar]
  • 28.Liang L, Gao T, Ren H, Cao R, Qin Z, Hu Y, et al. Post-traumatic stress disorder and psychological distress in Chinese youths following the COVID-19 emergency. J Health Psychol. 2020. August;25(9):1164–75. 10.1177/1359105320937057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Schönbrodt FD, Perugini M. At what sample size do correlations stabilize? J Res Pers. 2013. October;47(5):609–12. [Google Scholar]
  • 30.Buhrmester M, Kwang T, Gosling SD. Amazon’s Mechanical Turk: A New Source of Inexpensive, Yet High-Quality, Data? Perspect Psychol Sci. 2011. Jan;6(1):3–5. 10.1177/1745691610393980 [DOI] [PubMed] [Google Scholar]
  • 31.Casler K, Bickel L, Hackett E. Separate but equal? A comparison of participants and data gathered via Amazon’s MTurk, social media, and face-to-face behavioral testing. Comput Hum Behav. 2013. November;29(6):2156–60. [Google Scholar]
  • 32.Hauser DJ, Schwarz N. Attentive Turkers: MTurk participants perform better on online attention checks than do subject pool participants. Behav Res. 2016. March;48(1):400–7. 10.3758/s13428-015-0578-z [DOI] [PubMed] [Google Scholar]
  • 33.Peer E, Brandimarte L, Samat S, Acquisti A. Beyond the Turk: Alternative platforms for crowdsourcing behavioral research. J Exp Soc Psychol. 2017. May;70:153–63. [Google Scholar]
  • 34.Shapiro DN, Chandler J, Mueller PA. Using Mechanical Turk to study clinical populations. Clinical Psychological Science. 2013. April;1(2):213–20. [Google Scholar]
  • 35.Mellis AM, Bickel WK. Mechanical Turk data collection in addiction research: utility, concerns and best practices. Addiction. 2020;115(10):1960–8. 10.1111/add.15032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bai H. Evidence that a large amount of low quality responses on MTurk can be detected with repeated GPS coordinates [Internet]. 2018. [cited 2020 Sep 10]. Available from: https://www.maxhuibai.com/blog/evidence-that-responses-from-repeating-gps-are-random [Google Scholar]
  • 37.Stokel-Walker C. Bots on Amazon’s Mechanical Turk are ruining psychology studies [Internet]. New Scientist. 2018. [cited 2020 Sep 10]. Available from: https://www.newscientist.com/article/2176436-bots-on-amazons-mechanical-turk-are-ruining-psychology-studies/#ixzz5yQuyZGxM [Google Scholar]
  • 38.Moss A, Litman L. After the bot scare: Understanding what’s been happening with data collection on MTurk and how to stop it [Internet]. 2018. [cited 2020 Sep 12]. Available from: https://www.cloudresearch.com/resources/blog/after-the-bot-scare-understanding-whats-been-happening-with-data-collection-on-mturk-and-how-to-stop-it/ [Google Scholar]
  • 39.Berinsky AJ, Margolis MF, Sances MW. Separating the Shirkers from the Workers? Making Sure Respondents Pay Attention on Self-Administered Surveys. Am J Pol Sci. 2014;58(3):739–53. [Google Scholar]
  • 40.Hauser DJ, Schwarz N. It’s a Trap! Instructional Manipulation Checks Prompt Systematic Thinking on “Tricky” Tasks. SAGE Open. 2015. April 1;5(2):1–6. [Google Scholar]
  • 41.Bech P, Gudex C, Johansen KS. The WHO (Ten) Well-Being Index: validation in diabetes. Psychother Psychosom. 1996;65(4):183–90. 10.1159/000289073 [DOI] [PubMed] [Google Scholar]
  • 42.Marx BP, Schnurr PP, Lunney C, Weathers FW, Bovin MJ, Keane TM. Brief Inventory of Psychosocial Functioning (B-IPF). 2019; Available from: www.ptsd.va.gov [Google Scholar]
  • 43.Lovibond PF, Lovibond SH. The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995. March;33(3):335–43. 10.1016/0005-7967(94)00075-u [DOI] [PubMed] [Google Scholar]
  • 44.JASP Team. JASP. 2020.
  • 45.Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, et al. Psychometric properties of the PTSD Checklist for DSM-5 (PCL-5) in veterans. Psychol Assess. 2016. November;28(11):1379–91. 10.1037/pas0000254 [DOI] [PubMed] [Google Scholar]
  • 46.Sinclair SJ, Siefert CJ, Slavin-Mulford JM, Stein MB, Renna M, Blais MA. Psychometric evaluation and normative data for the Depression, Anxiety, and Stress Scales-21 (DASS-21) in a nonclinical sample of U.S. adults. Eval Health Prof. 2012. September;35(3):259–79. 10.1177/0163278711424282 [DOI] [PubMed] [Google Scholar]
  • 47.Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: A systematic review of the literature. Psychother Psychosom. 2015;84(3):167–76. 10.1159/000376585 [DOI] [PubMed] [Google Scholar]
  • 48.Molla R. Tech companies tried to help us spend less time on our phones. It didn’t work. 2020. January 6 [cited 2020 Sep 14]; Available from: https://www.vox.com/recode/2020/1/6/21048116/tech-companies-time-well-spent-mobile-phone-usage-data [Google Scholar]
  • 49.Funder DC, Ozer DJ. Evaluating effect size in psychological research: Sense and nonsense. AMPPS. 2019. Jun;2(2):156–68. [Google Scholar]
  • 50.Field A. Discovering statistics using SPSS. 2nd ed London: Sage; 2005. [Google Scholar]
  • 51.Rubin DC, Boals A, Berntsen D. Memory in posttraumatic stress disorder: Properties of voluntary and involuntary, traumatic and nontraumatic autobiographical memories in people with and without posttraumatic stress disorder symptoms. J Exp Psychol Gen. 2008;137(4):591–614. 10.1037/a0013165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Clark DM. Anxiety disorders: why they persist and how to treat them. Behav Res Ther. 1999. July;37:S5–27. 10.1016/s0005-7967(99)00048-0 [DOI] [PubMed] [Google Scholar]
  • 53.Wilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety. 2011. July;28(7):596–606. 10.1002/da.20837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Zachar P, McNally RJ. Vagueness, the sorites paradox, and posttraumatic stress disorder. In: International perspectives in philosophy and psychiatry Vagueness in psychiatry [Internet]. Oxford University Press; 2017. [cited 2020 Nov 24]. p. 169–88. Available from: http://oxfordmedicine.com/view/10.1093/med/9780198722373.001.0001/med-9780198722373-chapter-9 [Google Scholar]
  • 55.Brickman P, Campbell DT. Hedonic relativism and planning the good society In: Adaptation level theory: A symposium. New York, NY: Academic Press; 1971. p. 287–302. [Google Scholar]
  • 56.Taylor S, Landry CA, Paluszek MM, Fergus TA, McKay D, Asmundson GJG. COVID stress syndrome: Concept, structure, and correlates. Depress Anxiety. 2020. August;37(8):706–14. 10.1002/da.23071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Arpaci I, Karataş K, Baloğlu M. The development and initial tests for the psychometric properties of the COVID-19 Phobia Scale (C19P-S). Pers Individ Differ. 2020. October;164:110108 10.1016/j.paid.2020.110108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak [Internet]. 2020. [cited 2020 Apr 30]. Available from: https://www.who.int/docs/default-source/coronaviruse/mental-health-considerations.pdf [Google Scholar]
  • 59.Weathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, et al. The Clinician-Administered PTSD Scale for DSM–5 (CAPS-5): Development and Initial Psychometric Evaluation in Military Veterans. Psychol Assess. 2018. March;30(3):383–95. 10.1037/pas0000486 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Horesh D, Brown AD. Traumatic stress in the age of COVID-19: A call to close critical gaps and adapt to new realities. Psychol Trauma. 2020. May;12(4):331–5. 10.1037/tra0000592 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Vedat Sar

13 Nov 2020

PONE-D-20-29313

Why the COVID-19 pandemic is a traumatic stressor

PLOS ONE

Dear Dr. Takarangi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by date revision due. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Vedat Sar, M.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2) We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a well-organized manuscript which tries to build an alternative model of traumatic stress. They argue that traumatic stress reactions to the Covid-19 may relate more to future than past, indirect than direct exposures and stressful events that do not meet Criterion A.

There are a number of issues with the analysis and the interpretation of results that need to be addressed.

1. Within the flow of the introduction, the 3 features mentioned above have been discussed in order, but the cancer sample in P.5 117-1222 seems to be out of line.

2. Although it is understood from the whole of the introduction part that the authors aimed to determine the frequency of covid-related pre/post/peri traumatic stress reactions in the relevant population and to identify the factors that determine the severity of this stress, I recommend adding the primary and secondary objectives or hypothesis of the study clearly and explicitly.

3. I understand that 45.2% of the population had a Criterion A event in the past which reminds me that the index population can not be defined as a non-clinic population. It would be better to mention this unforeseeable feature as a limitation in the discussion.

4. The time interval should be specified in terms of having a sense of environmental and social conditions in that countries.

5. I wonder if the mean PCL-5 scores were significantly different between those 5 countries.

In this study, collecting data from 5 countries at different epidemic stages is an advantage in terms of generalizing the results, however, if the PCL-5 scores differ between countries, the geographical location should be included in the regression model as a variable.

6. A detailed statistical analysis part is missing within the Methods section. Especially the regression method used for predictive modeling should be added.

7. The prevalence of PTSD is 16.5% in direct exposure group whereas this rate is 11.5% in indirect exposure group.

The reason for being the majority of those with PTSD positive had indirect exposure is because the rate of indirect exposure in the sample is too high (direct exposure 327, indirect exposure 713). So, it is hard to say subjects with indirect exposure had similar PTSD rates with subjects who had direct exposures.

8. As you mentioned in P.19 414 the anticipated events may reflect generalized anxiety disorder. Do you have any explanatory hypothesis as to how these two concepts differ from each other?

Best Regards.

Reviewer #2: This study discusses COVID-19 as a traumatic stressor and focus on DSM-5 and its definitions. The study includes participants from different countries. The sample includes a good age range and authors describe how they accessed the participants and how they calculated the sample size. However, the manuscript is difficult to read and not well organized. In addition, there are many recent studies that study COVID-19 process as traumatic stress and this manuscript does not mention about them and does not discuss their findings and methodology compared to that studies.

As other important points,

1. The abstract is difficulty to read and does not present much information about the methodology and results. I suggest that the authors re-write the abstract and describe their methodology and results in more detail.

2. Introduction includes repeated explanations and needs to be tightened up.

3. Results and discussion sections are combined, which makes it difficult to follow. Statistical analysis are also reported in this section. They should be seperated with more specific subheadings.

4. In line 275, it is not clear how authors reach to such a definite conclusion with the previous reported result.

5. Authors do not discuss the current literature on the topic, but just discuss their findings from their own point of view.

6. Authors do not discuss the traumatic stress definitions done before the introduction of DSM-5.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Vedat Sar

28 Dec 2020

Why the COVID-19 pandemic is a traumatic stressor

PONE-D-20-29313R1

Dear Dr. Takarangi%,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

The only point I would recommend in the final version of the manuscript is, as the reviewer advices, to present the statistical analysis under a separate heading instead of being detailed within the conclusion section for ease of reading.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vedat Sar, M.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

As the reviewer recommends, n the final version of the manuscript, please present the statistical analysis under a separate heading instead of being detailed within the conclusion section for ease of reading.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All raised points have been addressed properly by authors. The only point I would recommend in the final version of the manuscript is to present the statistical analysis under a separate heading instead of being detailed within the conclusion section for ease of reading.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Vedat Sar

2 Jan 2021

PONE-D-20-29313R1

Why the COVID-19 pandemic is a traumatic stressor

Dear Dr. Takarangi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vedat Sar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The authors preregistered this experiment (https://osf.io/dxhek), and together with the data file, all supplementary material—including full demographic breakdown, analyses by country, and other descriptive and inferential statistics—can be found under this project: https://osf.io/jn7zx/.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES